Kengo Takeuchi

Geciteerd door

	Alles	Sinds 2019
Citaties	24010	10004
h-index	73	51
i10-index	217	162

1900

950

475

1425

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202473 91 90 103 139 248 340 618 966 1300 1454 1604 1728 1688 1633 1539 1566 1649 1883 1731 1630 1521

Openbare toegang

Alles bekijken

10 artikelen

2 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Yuki TogashiPathology Project for Molecular Targets, The Cancer Institute, JFCRGeverifieerd e-mailadres voor jfcr.or.jp
Ryohei KatayamaJapanese Foundation for Cancer ResearchGeverifieerd e-mailadres voor jfcr.or.jp
Seishi OgawaGeverifieerd e-mailadres voor umin.ac.jp
Akito DobashiThe Cancer Institute, Japanese Foundation for Cancer ResearchGeverifieerd e-mailadres voor umin.ac.jp
Noriko MotoiNational Cancer Center HospitalGeverifieerd e-mailadres voor umin.ac.jp
Tadashi YoshinoProfessor of Medicine, Okayama universityGeverifieerd e-mailadres voor md.okayama-u.ac.jp
luc fribouletGustave Roussy Université Paris SaclayGeverifieerd e-mailadres voor gustaveroussy.fr
Tetsuya MitsudomiKindai UniversityGeverifieerd e-mailadres voor med.kindai.ac.jp
Yuichi ShiraishiNational Cancer CenterGeverifieerd e-mailadres voor ncc.go.jp
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research InstituteGeverifieerd e-mailadres voor aichi-cc.jp
eiji shinozakiGeverifieerd e-mailadres voor jfcr.or.jp
Seiichi MoriGenome Center, Japanese Foundation for Cancer ResearchGeverifieerd e-mailadres voor jfcr.or.jp
Miyoshi HiroakiDepartment of Pathology, Kurume University, School of MedicineGeverifieerd e-mailadres voor med.kurume-u.ac.jp
Y. YATABEGeverifieerd e-mailadres voor ncc.go.jp
Hiroto NarimatsuDepartment of Public Health, Yamagata university graduate school of medicineGeverifieerd e-mailadres voor umin.org
Koichiro YujiProject Associate Professor, the Institute of Medical Science, the University of TokyoGeverifieerd e-mailadres voor umin.ac.jp
Hironori HagaKyoto UniversityGeverifieerd e-mailadres voor kuhp.kyoto-u.ac.jp
HIROSHI IWATABrigham and Women's HospitalGeverifieerd e-mailadres voor partners.org
藤井聡, Satoshi Fujii京都大学, Kyoto University, Goteborg UniversityGeverifieerd e-mailadres voor trans.kuciv.kyoto-u.ac.jp
Yoichi ImaiThe Institute of Medical Science, The University of TokyoGeverifieerd e-mailadres voor umin.ac.jp

Volgen

Kengo Takeuchi

Cancer Institute, Japanese Foundation for Cancer Research

Geverifieerd e-mailadres voor umin.net - Homepage

pathology surgical pathology molecular pathology hematopathology lymphoma


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
RET, ROS1 and ALK fusions in lung cancer K Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ... Nature Medicine 18 (3), 378-381, 2012	1620	2012
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors YL Choi, M Soda, Y Yamashita, T Ueno, J Takashima, T Nakajima, ... New England Journal of Medicine 363 (18), 1734-1739, 2010	1467	2010
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer K Takeuchi, YL Choi, Y Togashi, M Soda, S Hatano, K Inamura, S Takada, ... Clinical cancer research 15 (9), 3143-3149, 2009	914	2009
Integrated molecular analysis of adult T cell leukemia/lymphoma K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi, T Shimamura, J Yasunaga, ... Nature genetics 47 (11), 1304-1315, 2015	838	2015
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma M Sakata-Yanagimoto, T Enami, K Yoshida, Y Shiraishi, R Ishii, Y Miyake, ... Nature genetics 46 (2), 171-175, 2014	728	2014
A mouse model for EML4-ALK-positive lung cancer M Soda, S Takada, K Takeuchi, YL Choi, M Enomoto, T Ueno, H Haruta, ... Proceedings of the National Academy of Sciences 105 (50), 19893, 2008	701	2008
Frequent inactivation of A20 in B-cell lymphomas M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ... Nature 459 (7247), 712-716, 2009	687	2009
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers K Kataoka, Y Shiraishi, Y Takeda, S Sakata, M Matsumoto, S Nagano, ... Nature 534 (7607), 402-406, 2016	684	2016
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study T Seto, K Kiura, M Nishio, K Nakagawa, M Maemondo, A Inoue, T Hida, ... The lancet oncology 14 (7), 590-598, 2013	680	2013
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts K Takeuchi, YL Choi, M Soda, K Inamura, Y Togashi, S Hatano, ... Clinical cancer research 14 (20), 6618-6624, 2008	628	2008
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers K Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ... Journal of Thoracic Oncology 3 (1), 13, 2008	596	2008
Identification of novel isoforms of the EML4-ALK transforming gene in non–small cell lung cancer YL Choi, K Takeuchi, M Soda, K Inamura, Y Togashi, S Hatano, ... Cancer research 68 (13), 4971-4976, 2008	581	2008
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients T Oyama, K Yamamoto, N Asano, A Oshiro, R Suzuki, Y Kagami, ... Clinical cancer research 13 (17), 5124-5132, 2007	563	2007
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ... Modern pathology 22 (4), 508-515, 2009	557	2009
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib R Katayama, L Friboulet, S Koike, EL Lockerman, TM Khan, JF Gainor, ... Clinical cancer research 20 (22), 5686-5696, 2014	335	2014
KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only Y Togashi, M Soda, S Sakata, E Sugawara, S Hatano, R Asaka, ... PloS one 7 (2), e31323, 2012	316	2012
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations N Tomita, M Tokunaka, N Nakamura, K Takeuchi, J Koike, S Motomura, ... Haematologica 94 (7), 935-943, 2009	266	2009
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype R Suzuki, Y Kagami, K Takeuchi, M Kami, M Okamoto, R Ichinohasama, ... Blood 96 (9), 2993-3000, 2000	259	2000
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer B Gong, K Kiyotani, S Sakata, S Nagano, S Kumehara, S Baba, B Besse, ... Journal of Experimental Medicine 216 (4), 982-1000, 2019	235	2019
TRANSPLANTATION-Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease Y Sakoda, D Hashimoto, S Asakura, K Takeuchi, M Harada, M Tanimoto, ... Blood 109 (4), 1756, 2010	209*	2010

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs